Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2007-10-23
2007-10-23
Richter, Johann (Department: 1616)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C514S635000
Reexamination Certificate
active
10472229
ABSTRACT:
The present invention relates to biguanide derivatives of formula (I), wherein R1, R2, R3 and R4 have the meanings as given in claim (1). Compounds are useful in the treatment of pathologies associated with hyperglycaemia, such as diabetes.
REFERENCES:
patent: 2937173 (1960-05-01), Shapiro et al
patent: 3879541 (1975-04-01), Kabbe et al.
patent: 3960949 (1976-06-01), Ahrens et al.
patent: 4333929 (1982-06-01), Cantello
patent: 0034002 (1981-08-01), None
patent: 2085665 (1971-12-01), None
patent: 2696740 (1994-04-01), None
patent: 852584 (1960-10-01), None
patent: 61-41367 (1988-02-01), None
STN online, file CAPLUS, Acc. No. 1986:425797, Doc. No. 105:25797 (JP 61041367 (1986)), Abstract.
Hawley's Condensed Chemical Dictionary (14th Ed. 2002) (http://www. knovel.com/knovel2/Toc.jsp?BookID=704&VerticalID=0), “epimer”.
Shapiro et al., Hypoglycemic Agents. III. N-alkyl-and Aralkylbiguanides. Journal of the American Chemical Society (1959), vol. 81, pp. 3728-3736.
Wikipedia, the free encyclopedia (2006)(http://en.wikipedia.org/wiki/Stereoisomerism), pp. 1-3.
The Merck Index (11thEd. 1989), pp. 672, 1267, 1274, 1452.
John W. James et al., “The Synthesis of some heterocyclic derivatives of biguanide with antibacterial activity”, Journal of Medicinal Chemistry, vol. 11, No. 5, 1968, pp. 942-945.
Cravo Daniel
Moinet Gerard
Choi Frank
Merck Patent Gesellschaft
Millen White Zelano & Branigan P.C.
LandOfFree
Biguanide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biguanide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biguanide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3896928